160 related articles for article (PubMed ID: 30216232)
1. The Frequency of Discordant Gyrase A Genotypes Among Cases of Multiple Neisseria gonorrhoeae Infections at Different Anatomic Sites.
Allan-Blitz LT; Ellis OL; Bolan R; Hemarajata P; Humphries RM; Shahkolahi A; McGrath M; Klausner JD
Sex Transm Dis; 2019 Jan; 46(1):e3-e4. PubMed ID: 30216232
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Neisseria gonorrhoeae Gyrase A Genotype, Los Angeles, California, USA.
Bhatti AA; Allan-Blitz LT; Castrejon M; Humphries RM; Hemarajata P; Klausner JD
Emerg Infect Dis; 2017 Sep; 23(9):1581-1584. PubMed ID: 28820375
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin May be Efficacious in Treating Wild-Type Gyrase A Genotype Neisseria gonorrhoeae Infections.
Allan-Blitz LT; Hemarajata P; Humphries RM; Kimble M; Elias S; Klausner JD
Sex Transm Dis; 2018 Apr; 45(4):e18. PubMed ID: 29465685
[No Abstract] [Full Text] [Related]
4. Wild-Type Gyrase A Genotype of Neisseria gonorrhoeae Predicts In Vitro Susceptibility to Ciprofloxacin: A Systematic Review of the Literature and Meta-Analysis.
Allan-Blitz LT; Wang X; Klausner JD
Sex Transm Dis; 2017 May; 44(5):261-265. PubMed ID: 28407640
[TBL] [Abstract][Full Text] [Related]
5. A multisite implementation of a real-time polymerase chain reaction assay to predict ciprofloxacin susceptibility in Neisseria gonorrhoeae.
Ellis O; Hemarajata P; Shahkolahi A; Masinde G; Buchs K; Humphries RM; Klausner JD
Diagn Microbiol Infect Dis; 2019 Jul; 94(3):213-217. PubMed ID: 30723007
[TBL] [Abstract][Full Text] [Related]
6. A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection.
Allan-Blitz LT; Hemarajata P; Humphries RM; Wynn A; Segura ER; Klausner JD
Sex Transm Dis; 2018 Feb; 45(2):87-91. PubMed ID: 29329176
[TBL] [Abstract][Full Text] [Related]
7. Improved determination of Neisseria gonorrhoeae gyrase A genotype results in clinical specimens.
Allan-Blitz LT; Ellis OL; Wee R; Truong A; Ebeyan SM; Tan LY; Mokany E; Flynn R; Klausner JD
J Antimicrob Chemother; 2019 Oct; 74(10):2913-2915. PubMed ID: 31340021
[TBL] [Abstract][Full Text] [Related]
8. Performance and Verification of a Real-Time PCR Assay Targeting the gyrA Gene for Prediction of Ciprofloxacin Resistance in Neisseria gonorrhoeae.
Hemarajata P; Yang S; Soge OO; Humphries RM; Klausner JD
J Clin Microbiol; 2016 Mar; 54(3):805-8. PubMed ID: 26739156
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae.
Ebeyan S; Windsor M; Bordin A; Mhango L; Erskine S; Trembizki E; Mokany E; Tan LY; Whiley D;
J Antimicrob Chemother; 2019 Jul; 74(7):1820-1824. PubMed ID: 30897201
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
[TBL] [Abstract][Full Text] [Related]
11. Addressing Neisseria gonorrhoeae Treatment Resistance With the DNA Gyrase A Assay: An Economic Study, United States.
Wynn A; Klausner JD
Sex Transm Dis; 2020 Feb; 47(2):111-113. PubMed ID: 31688726
[TBL] [Abstract][Full Text] [Related]
12. Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System.
Allan-Blitz LT; Humphries RM; Hemarajata P; Bhatti A; Pandori MW; Siedner MJ; Klausner JD
Clin Infect Dis; 2017 May; 64(9):1268-1270. PubMed ID: 28034887
[TBL] [Abstract][Full Text] [Related]
13. Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914).
Su XH; Wang BX; Le WJ; Liu YR; Wan C; Li S; Alm RA; Mueller JP; Rice PA
Antimicrob Agents Chemother; 2016 Jan; 60(1):621-3. PubMed ID: 26482313
[TBL] [Abstract][Full Text] [Related]
14. Molecular Assay for Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae Isolates from Cultures and Clinical Nucleic Acid Amplification Test Specimens.
Peterson SW; Martin I; Demczuk W; Bharat A; Hoang L; Wylie J; Allen V; Lefebvre B; Tyrrell G; Horsman G; Haldane D; Garceau R; Wong T; Mulvey MR
J Clin Microbiol; 2015 Nov; 53(11):3606-8. PubMed ID: 26292300
[TBL] [Abstract][Full Text] [Related]
15. High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae.
Dewi BE; Akira S; Hayashi H; Ba-Thein W
Sex Transm Dis; 2004 Jun; 31(6):353-9. PubMed ID: 15167645
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance patterns (1999-2002) and characterization of ciprofloxacin-resistant Neisseria gonorrhoeae in Korea.
Yoo J; Yoo C; Cho Y; Park H; Oh HB; Seong WK
Sex Transm Dis; 2004 May; 31(5):305-10. PubMed ID: 15107634
[TBL] [Abstract][Full Text] [Related]
17. Mutations in gyrA and parC in ciprofloxacin-resistant Neisseria gonorrhoeae in Kuala Lumpur, Malaysia.
Karunakaran R; Sam IC
J Antimicrob Chemother; 2007 Apr; 59(4):803-4. PubMed ID: 17329273
[No Abstract] [Full Text] [Related]
18. Frequency of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in 19 clinical isolates of Neisseria gonorrhoeae in Tokyo in 2002.
Abe H; Nishimura T; Norose Y; Aoto T; Ohzuka H; Ohkuni H
J Infect Chemother; 2003 Dec; 9(4):310-3. PubMed ID: 14691651
[TBL] [Abstract][Full Text] [Related]
19. Detection of gyrA mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by rapid and reliable pre-programmed short DNA sequencing.
Gharizadeh B; Akhras M; Unemo M; Wretlind B; Nyrén P; Pourmand N
Int J Antimicrob Agents; 2005 Dec; 26(6):486-90. PubMed ID: 16274961
[TBL] [Abstract][Full Text] [Related]
20. Frequency of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in 19 clinical isolates of Neisseria gonorrhoeae in Tokyo in 2002.
Sato K
J Infect Chemother; 2003 Dec; 9(4):361. PubMed ID: 14691662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
